ArriVent BioPharma, Inc. (AVBP) SEC Filings & Financial Intelligence
ArriVent BioPharma, Inc. (AVBP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AVBP
CIK: 1868279
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerAlexander Raymond
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-13 | — | SCHEDULE 13G Filing | 0001213900-26-109019 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-12 | FORM 8-K | 0001104659-26-115161 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-10-08 | — | SCHEDULE 13D/A Filing | 0000947871-26-000931 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | FORM 8-K | 0001104659-26-113898 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001104659-26-094902 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-11 | FORM 8-K | 0001104659-26-094869 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002185 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076570 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076569 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076567 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076566 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | FORM 8-K | 0001104659-26-076352 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | FORM 8-K | 0001104659-26-058706 | View SEC Doc Filr Page |
| 424B5 | 2026-05-11 | — | 424B5 | 0001104659-26-058700 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001104659-26-058650 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001104659-26-058638 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001106 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | ARS | 0001104659-26-050350 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001104659-26-050344 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-28 | 2026-06-18 | FORM- DEF 14A | 0001104659-26-050337 | View SEC Doc Filr Page |
| 8-K | 2026-03-17 | 2026-03-17 | 8-K | 0001104659-26-029588 | View SEC Doc Filr Page |
| S-8 | 2026-03-05 | — | FORM S-8 | 0001104659-26-024136 | View SEC Doc Filr Page |
| 10-K | 2026-03-05 | 2025-12-31 | 10-K | 0001104659-26-024127 | View SEC Doc Filr Page |
| 8-K | 2026-03-05 | 2026-03-05 | 8-K | 0001104659-26-024112 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-05 | — | SCHEDULE 13G/A Filing | 0001104659-26-023750 | View SEC Doc Filr Page |